Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs GSK✓SelectedUSD · GSKALAB vs GSK performance historyLatest closeAs of+4.58%11/17
Stock and ETF performance explorer

ALAB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+241.1%
GSK return
+30.3%
Excess return
+210.8%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+4.6%-2.3%+6.9%+4.0%
7D-2.1%-3.0%+0.9%-2.8%
30D-26.0%+0.4%-26.3%-25.7%
3M-33.9%-1.2%-32.7%-33.6%
6M-9.1%+0.9%-10.0%-8.2%
YTD+27.2%+4.0%+23.2%+29.5%
1Y+49.7%+7.3%+42.4%+53.0%
All+241.1%+30.3%+210.8%+303.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling